ARTICLE | Company News
Aposense, Roche deal
November 15, 2010 8:00 AM UTC
Roche received a non-exclusive license to use Aposense's EarliTest technology in Roche's oncology development. Roche will use EarliTest, which comprises a ML-10 apoptosis imaging agent, to monitor tum...